Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

PALI Palisade Bio Inc

1,65

-0,05 (-2,94%)

01 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

null

Palisade Bio (NASDAQ:PALI)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Palisade Bio Charts.

Palisade Bio (NASDAQ:PALI)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Palisade Bio Charts.

News Palisade Bio Inc

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 17 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 17 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 17 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Palisade Bio Appoints Brian Feagan, MD, FRCPC, to its Clinical Advisory Board
Dienstag 17 Dezember 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Dienstag 17 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 16 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Palisade Bio Announces Closing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
Freitag 13 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 13 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Freitag 13 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Palisade Bio Announces Pricing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
Donnerstag 12 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Montag 9 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Donnerstag 5 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Weitere Palisade Bio Inc News-Artikel

Health Care Select Sector

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen